Cytarabine FDA Approved Drugs
CYTARABINE [CytarabineC9H13N3O5]
RX
- 100mg/ml (injection injectable)
100mg/vial (injection injectable)
1gm/vial (injection injectable)
20mg/ml (injection injectable)
2gm/vial (injection injectable)
500mg/vial (injection injectable)
Fresenius Kabi UsaJan 15, 2004
HospiraNov 22, 1999
Mylan Labs LtdJan 30, 2012
West-ward Pharms IntAug 2, 1989
Mylan Pharms IncDec 13, 2011
HospiraNov 22, 1999
Mylan Labs LtdJan 30, 2012
West-ward Pharms IntAug 2, 1989
Mylan Pharms IncDec 13, 2011
DEPOCYT [CytarabineC9H13N3O5]
RX
- 10mg/ml (injection injectable, liposomal)
Pacira Pharms IncApr 1, 1999
RYDAPT [MidostaurinC35H30N4O4]
RX
- 25mg (oral capsule)
Novartis Pharms CorpApr 28, 2017
- Treatment of adult patients with aggressive systemic mastocytosis (asm), systemic mastocytosis with associated hematological neoplasm (sm-ahn), or mast cell leukemia (mcl).
- Treatment of adult patients with newly diagnosed acute myeloid leukemia (aml) who are flt3 mutation-positive, in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.